MyFinsight
Home
Blog
About
Cash and cash
equivalents
$181,815K
(31.23%↑ Y/Y)
Marketable securities
$29,830K
(-25.35%↓ Y/Y)
Prepaid expenses and
other current assets
$3,697K
(-0.27%↓ Y/Y)
Accounts receivable
$2,725K
(363.44%↑ Y/Y)
Total current assets
$218,067K
(19.30%↑ Y/Y)
Right-of-use assets
$13,747K
(-27.69%↓ Y/Y)
Restricted cash and other
non-current assets
$2,976K
(-29.11%↓ Y/Y)
Property and equipment,
net
$2,574K
(-43.75%↓ Y/Y)
Total assets
$237,364K
(12.72%↑ Y/Y)
Total liabilities and
stockholders equity
$237,364K
(12.72%↑ Y/Y)
Total liabilities
$132,083K
(-30.99%↓ Y/Y)
Total stockholders
equity
$105,281K
(448.65%↑ Y/Y)
Accumulated deficit
-$1,671,715K
(-4.63%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$6K
(-140.00%↓ Y/Y)
Total current
liabilities
$68,434K
(3.79%↑ Y/Y)
Liability for sale of
future revenues, net of...
$48,238K
(-6.64%↓ Y/Y)
Operating lease
liabilities, net of current...
$8,998K
(-39.97%↓ Y/Y)
Deferred revenue, net of
current portion
$4,000K
(-92.62%↓ Y/Y)
Other non-current
liabilities
$2,413K
(-47.45%↓ Y/Y)
Additional paid-in capital
$1,776,987K
(9.90%↑ Y/Y)
Common stock, 0.0001
par value per share...
$15K
(66.67%↑ Y/Y)
Deferred revenue,
current
$32,315K
Accrued expenses
$17,365K
(-63.87%↓ Y/Y)
Liability for sale of
future revenues,...
$7,500K
(50.00%↑ Y/Y)
Operating lease
liabilities, current
$6,513K
(5.97%↑ Y/Y)
Accounts payable
$4,741K
(-29.48%↓ Y/Y)
Back
Back
Balance Sheet
Editas Medicine, Inc. (EDIT)
Editas Medicine, Inc. (EDIT)
source: myfinsight.com